HAE

HAEMONETICS CORPORATION

HAE · CIK 313143 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.4B
20182025
Net Income$0.2B
20182025
Operating CF$0.2B
20182025
Free Cash Flow$0.1B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.4B$1.3B——————
Cost of Revenue$0.6B$0.6B$0.6B$0.5B$0.5B$0.5B$0.6B—
Gross Profit$0.7B$0.7B$0.6B$0.5B$0.1B$0.1B$0.1B$0.1B
R&D Expense$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.4B$0.4B$0.4B$0.3B$0.3B$0.3B$0.3B$0.3B
Operating Income$0.2B$0.2B$0.2B$0.1B$-0.0B$0.0B$0.0B$0.0B
Net Income$0.2B$0.1B$0.1B$0.0B$-0.0B$0.0B$0.0B$0.0B
EPS (Basic)$3.33$2.32$2.27$0.85$-0.22$0.35$0.41$0.22
EPS (Diluted)$3.31$2.29$2.24$0.84$-0.22$0.34$0.40$0.22

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$2.5B$2.2B$1.9B$1.9B$1.8B$1.3B$1.3B$1.2B
Current Assets$0.9B$0.8B$0.8B$0.8B$0.7B$0.6B$0.6B$0.5B
Cash & Equivalents$0.3B$0.2B$0.3B$0.3B$0.2B$0.1B$0.2B$0.2B
Total Liabilities————————
Current Liabilities$0.6B$0.3B$0.3B$0.4B$0.3B$0.3B$0.2B$0.4B
Stockholders' Equity$0.8B$1.0B$0.8B$0.7B$0.7B$0.6B$0.7B$0.8B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.2B$0.2B$0.3B$0.2B$0.1B$0.2B$0.2B$0.2B
Investing Cash Flow$-0.2B$-0.3B$-0.1B$-0.1B$-0.4B$-0.1B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.1B$0.1B$0.1B$0.0B$0.0B$0.1B$0.1B
Financing Cash Flow$0.1B$0.0B$-0.1B$-0.0B$0.4B$-0.1B$-0.1B$-0.1B
← Companies